Journal
JOURNAL OF CLINICAL PHARMACOLOGY
Volume 46, Issue 4, Pages 418-423Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/0091270006286435
Keywords
etanercept; Japanese; pharmocokinetics; TNFR; rheumatoid arthritis
Categories
Ask authors/readers for more resources
Thirty Japanese (J) and 32 American (A) healthy Subjects received single doses of etanercept by subcutaneous injection, in 3 separate trials. Serum samples were collected for 480 hours after dosing. Concentrations were determined using enzyme-linked immunosorbent assay methods. Pharmacokinetic parameters were calculated using both non-compartmental and compartmental methods. Etanercept vas slowly absorbed. with mean +/- SD time to maximum serum concentration of 47 +/- 15 hours (J), and 51 +/- 20 hours (A). The maximum serum concentration and area under the concentration time curve increased for doses 10 mg, 25 mg and 50 mg, in a linear relationship. Etanercept was slowly eliminated, with observed mean +/- SD half-life of 80 +/- 25 hours (J) and 75 15 hours (A) and mean SD apparent clearance of 144 +/- 65 mL/h (J) and 132 +/- 74 mL/h (A). Very low, concentrations of etanercept were observed in the urine samples collected in the Japanese subjects. All adverse reactions observed resolved without issue, and none required discontinuation from the study.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available